What is the primary purpose of mitoxantrone (Novantrone) in MS treatment?

Mitoxantrone is primarily used in the treatment of multiple sclerosis as a disease-modifying therapy. Its main function is to slow down the progression of the disease, particularly in patients with both secondary progressive and relapsing forms of MS who have not responded to other treatments. Mitoxantrone works by immunosuppressive mechanisms, reducing the frequency of relapses and the formation of new lesions on MRI scans.

It is specifically indicated for its ability to modify the underlying disease course rather than merely addressing symptoms. While managing fatigue, pain relief, and managing acute symptoms are important aspects of comprehensive MS care, they are not the primary role of mitoxantrone. The focus on modifying the disease progression in MS is crucial, as it aims to enhance overall long-term outcomes for patients with this condition.